We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$45.3M
2
MDVN
MEDIVATION, INC.
MDVN
+$33.2M
3
DHR icon
Danaher
DHR
+$28.3M
4
FLTX
Fleetmatics Group PLC
FLTX
+$25.2M
5
HCSG icon
Healthcare Services Group
HCSG
+$24.7M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SJT
1201
San Juan Basin Royalty Trust
SJT
$113M
$83K ﹤0.01%
14,000
– –
PSEC icon
1202
Prospect Capital
PSEC
$1.11B
$81K ﹤0.01%
10,000
-3,450
-26% -$28.5K
AWRE icon
1203
Aware
AWRE
$26.4M
$80K ﹤0.01%
15,000
-500
-3% -$2.51K
SLM icon
1204
SLM Corp
SLM
$5.09B
$77K ﹤0.01%
+10,357
New +$74.4K
HIO
1205
Western Asset High Income Opportunity Fund
HIO
$336M
$76K ﹤0.01%
+14,980
New +$75.2K
GYB.CL
1206
DELISTED
Corporate Asset Backed Corp., CABCO Trust 2004-101 Goldman Sachs Float
GYB.CL
$70K ﹤0.01%
+3,100
New +$68.3K
KTOS icon
1207
Kratos Defense & Security Solutions
KTOS
$9.23B
$69K ﹤0.01%
10,000
– –
KPN
1208
DELISTED
ROYAL KPN NV ADS (EA REPTG 1 ORD SH)
KPN
$66K ﹤0.01%
19,586
+108
+0.6% +$364
MWW
1209
DELISTED
Monster Worldwide Inc
MWW
$63K ﹤0.01%
17,500
-2,850
-14% -$9.07K
SREV
1210
CALL
DELISTED
ServiceSource International, Inc.
SREV
$56K ﹤0.01%
+11,500
New +$54.1K
MIN
1211
Aberdeen Intermediate Income Fund
MIN
$274M
$55K ﹤0.01%
+12,224
New +$56.2K
UEC icon
1212
Uranium Energy
UEC
$4.93B
$55K ﹤0.01%
55,555
– –
SVU
1213
DELISTED
SUPERVALU Inc.
SVU
$53K ﹤0.01%
1,521
– –
SGMO
1214
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$52K ﹤0.01%
11,300
+900
+9% +$4.58K
INFI
1215
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$51K ﹤0.01%
32,730
-400
-1% -$615
TACOW
1216
DELISTED
Del Taco Restaurants, Inc. Warrants
TACOW
$48K ﹤0.01%
12,500
– –
BFF
1217
DELISTED
BFC FIN'L CP CL A
BFF
$48K ﹤0.01%
12,500
– –
NGD
1218
DELISTED
New Gold Inc
NGD
$44K ﹤0.01%
+10,000
New +$49.9K
LYG icon
1219
Lloyds Banking Group
LYG
$90.9B
$42K ﹤0.01%
14,587
-37,722
-72% -$112K
SRRA
1220
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$33K ﹤0.01%
460
+43
+10% +$3.32K
LIME
1221
DELISTED
LIME ENERGY CO.NEW COMMON STOCK
LIME
$31K ﹤0.01%
+14,704
New +$31.3K
DRRX
1222
DELISTED
DURECT Corp
DRRX
$24K ﹤0.01%
1,694
– –
ATHX
1223
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K ﹤0.01%
400
– –
ENSV
1224
DELISTED
Enservco Corp.
ENSV
$20K ﹤0.01%
2,300
– –
MVIS icon
1225
Microvision
MVIS
$89.9M
$17K ﹤0.01%
825
– –
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.